Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.
about
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.Specialized Information Processing Deficits and Distinct Metabolomic Profiles Following TM-Domain Disruption of Nrg1.Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks.Cannabinoid-glutamate interactions and neural oscillations: implications for psychosis.Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.
P2860
Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.
@en
type
label
Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.
@en
prefLabel
Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.
@en
P2093
P2860
P921
P1476
Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.
@en
P2093
Alexander Neumeister
Beata Planeta
Brian Pittman
David Labaree
Deepak Cyril D'Souza
Halle Thurnauer
Jose Cortes-Briones
Mohini Ranganathan
Patrick Skosnik
P2860
P304
P356
10.1016/J.BIOPSYCH.2015.08.021
P407
P577
2015-08-29T00:00:00Z